Related Experiment Video
Updated: Sep 11, 2025

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
621
A Pathology-Based Risk Stratification Model for Predicting Occult Lesions in Papillary Thyroid Carcinoma Patients:
Han-Xiao Zhao1,2, Yun Niu3, Ying Wei2
1China-Japan Friendship Institute of Clinical Medical Sciences, Beijing, China.
World Journal of Surgery
|August 13, 2025
Summary
A new prediction model identifies patients at high risk for new papillary thyroid carcinoma (PTC) tumors after thermal ablation (TA). This tool aids clinicians in tailoring follow-up care for PTC patients treated with TA.
Area of Science:
- Oncology
- Minimally Invasive Surgery
Background:
- Thermal ablation (TA) is a minimally invasive treatment for papillary thyroid carcinoma (PTC).
- Sonographically occult lesions can lead to new tumor development post-TA, necessitating risk identification.
- Developing a predictive model is crucial for managing patients undergoing TA for PTC.
Purpose of the Study:
- To develop and validate a prediction model for identifying patients at high risk of new tumor development after TA for PTC.
- To stratify patients into risk groups based on identified factors.
- To provide an evidence-based tool for individualized follow-up strategies.
Main Methods:
- Retrospective analysis of pathological results from total thyroidectomy patients to identify risk factors for occult lesions.
- Development of a prediction model based on identified risk factors (tumor stage, multifocality).
- External validation of the model in patients who received TA with over 5 years of follow-up.
Main Results:
- Two independent risk factors for occult thyroid lesions were identified: tumor stage and multifocality.
- The prediction model demonstrated good discrimination with an AUC of 0.717 (internal validation: 0.769).
- External validation in 290 patients confirmed the model's effectiveness in predicting new tumor development (AUC: 0.755).
Conclusions:
- A risk-stratified prediction model for occult lesions has been developed and validated.
- This model serves as an evidence-based tool for clinicians.
- The model aids in estimating new tumor risk and guiding individualized follow-up strategies after TA for PTC.

